Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,016 | 5,175 | 20,761 | 5,486 | 3,625 |
| Depreciation Amortization | 429 | 229 | 984 | 748 | 508 |
| Income taxes - deferred | 71 | -69 | -47 | -213 | -213 |
| Accounts receivable | -212 | -53 | 36 | 120 | -167 |
| Accounts payable and accrued liabilities | 165 | 198 | -291 | -89 | -24 |
| Other Working Capital | 16,130 | 19,291 | -14,371 | -888 | -855 |
| Other Operating Activity | 231 | -82 | 1,263 | 856 | 408 |
| Operating Cash Flow | $23,830 | $24,689 | $8,335 | $6,020 | $3,282 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -259 | -189 | -272 | -147 | -123 |
| Net Acquisitions | -1,012 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -22,103 | -21,903 | -737 | N/A | N/A |
| Sale Of Investment | 2,168 | N/A | 98 | N/A | N/A |
| Purchase Sale Intangibles | -10 | -10 | -122 | -66 | N/A |
| Other Investing Activity | -11 | -10 | -122 | -66 | 0 |
| Investing Cash Flow | $-21,217 | $-22,102 | $-1,033 | $-213 | $-123 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -4,956 | -4,956 | -3,088 |
| Common Stock Issued | 1,012 | 199 | 882 | 710 | 382 |
| Common Stock Repurchased | -3,063 | -2,690 | -2,795 | -941 | -456 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1 |
| Financing Cash Flow | $-2,051 | $-2,491 | $-6,869 | $-5,187 | $-3,163 |
| Exchange Rate Effect | -14 | -8 | 44 | 20 | 18 |
| Beginning Cash Position | 762 | 762 | 285 | 285 | 285 |
| End Cash Position | 1,311 | 850 | 762 | 925 | 300 |
| Net Cash Flow | $549 | $88 | $477 | $640 | $15 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,830 | 24,689 | 8,335 | 6,020 | 3,282 |
| Capital Expenditure | -259 | -189 | -272 | -147 | -123 |
| Free Cash Flow | 23,571 | 24,500 | 8,063 | 5,873 | 3,159 |